Literature DB >> 8849687

Requirements for antibacterial and hemolytic activities in the bovine neutrophil derived 13-residue peptide indolicidin.

C Subbalakshmi1, V Krishnakumari, R Nagaraj, N Sitaram.   

Abstract

The antimicrobial and hemolytic activities of the 13-residue peptide indolicidin (ILPWKWPWWPWRR-NH2), present in bovine neutrophils, and its analogs have been determined with a view to gaining insight into the structural roles of tryptophan and proline. Peptides where proline was replaced by alanine and tryptophan by phenylalanine showed antibacterial activities comparable to that of indolicidin. The peptides do not exhibit a strong propensity to occur in either helical or beta-sheet conformation. The peptides also do not appear to exert their activity by permeabilizing the bacterial plasma membrane unlike other endogenous antibacterial peptides. The presence of tryptophan appears to be essential for hemolytic activity as the phenylalanine analog does not exhibit any hemolytic activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8849687     DOI: 10.1016/0014-5793(96)00996-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  31 in total

1.  Structure-function analysis of tritrpticin analogs: potential relationships between antimicrobial activities, model membrane interactions, and their micelle-bound NMR structures.

Authors:  David J Schibli; Leonard T Nguyen; Stephanie D Kernaghan; Øystein Rekdal; Hans J Vogel
Journal:  Biophys J       Date:  2006-09-22       Impact factor: 4.033

2.  Importance of the membrane-perturbing properties of the membrane-proximal external region of human immunodeficiency virus type 1 gp41 to viral fusion.

Authors:  Sundaram A Vishwanathan; Eric Hunter
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

3.  Molecular dynamics simulations of indolicidin association with model lipid bilayers.

Authors:  Jenny C Y Hsu; Christopher M Yip
Journal:  Biophys J       Date:  2007-04-06       Impact factor: 4.033

4.  Effect of micelle interface on the binding of anticoccidial PW2 peptide.

Authors:  Luzineide W Tinoco; Francisco Gomes-Neto; Ana Paula Valente; Fabio C L Almeida
Journal:  J Biomol NMR       Date:  2007-10-10       Impact factor: 2.835

5.  Synthesis and characterization of bactericidal oligopeptides designed on the basis of an insect anti-bacterial peptide.

Authors:  H Saido-Sakanaka; J Ishibashi; A Sagisaka; E Momotani; M Yamakawa
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

Review 6.  Intracellular Targeting Mechanisms by Antimicrobial Peptides.

Authors:  Cheng-Foh Le; Chee-Mun Fang; Shamala Devi Sekaran
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

7.  Antibacterial properties of the sperm-binding proteins and peptides of human epididymis 2 (HE2) family; salt sensitivity, structural dependence and their interaction with outer and cytoplasmic membranes of Escherichia coli.

Authors:  Suresh Yenugu; Katherine G Hamil; Charles E Birse; Steven M Ruben; Frank S French; Susan H Hall
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

8.  Comparison of the membrane association of two antimicrobial peptides, magainin 2 and indolicidin.

Authors:  H Zhao; J P Mattila; J M Holopainen; P K Kinnunen
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

Review 9.  Archetypal tryptophan-rich antimicrobial peptides: properties and applications.

Authors:  Nadin Shagaghi; Enzo A Palombo; Andrew H A Clayton; Mrinal Bhave
Journal:  World J Microbiol Biotechnol       Date:  2016-01-09       Impact factor: 3.312

10.  Temporin L: antimicrobial, haemolytic and cytotoxic activities, and effects on membrane permeabilization in lipid vesicles.

Authors:  Andrea C Rinaldi; Maria Luisa Mangoni; Anna Rufo; Carla Luzi; Donatella Barra; Hongxia Zhao; Paavo K J Kinnunen; Argante Bozzi; Antonio Di Giulio; Maurizio Simmaco
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.